Browse our anti-S-100 Protein (alpha chain) Antibodies

Human S-100 Protein (alpha chain) interaction partners

1. Results showed that our prepared S100B (show S100B Antibodies) mAbs were suitable for detecting S100B (show S100B Antibodies) expression in human tissues, furnishing promising tools for further functional investigation and clinical applications.

2. In this study demonstrated that S100b (show S100B Antibodies) is elevated in Alzheimer disease cases. and the increased levels in African Americans here may be indicative of increased severity in specific populations.

3. In neonates, NSE (show ENO2 Antibodies) and s100B (show S100B Antibodies) levels increase after bypass surgery and return below preoperative baseline levels by postoperative day seven. The levels of s100B (show S100B Antibodies) were positively correlated with circulatory arrest time and negatively correlated with age at time of surgery.

4. found that S100B (show S100B Antibodies) plays a crucial role in blocking the interaction site between RAGE (show AGER Antibodies) V domain and S100A1 (show S100A1 Antibodies). A cell proliferation assay WST (show EEF1A2 Antibodies)-1 also supported our results. This report could potentially be useful for new protein development for cancer treatment

5. the serum levels of S100B (show S100B Antibodies) protein mediated the association between S100B (show S100B Antibodies) gene polymorphism and scene selectivity in the retrosplenial cortex

6. There is a significant correlation between mortality in the critically ill patients in the intensive care unit and increased serum concentration of S100B (show S100B Antibodies) and NSE (show ENO2 Antibodies).

7. Our findings showed that both S100beta and NSE (show ENO2 Antibodies) levels similarly increased during CPB (show CPB1 Antibodies) and immediately after CPB (show CPB1 Antibodies) during sevoflurane and propofol based anesthesia.

8. This study demonstrated that S100A12 (show S100A12 Antibodies) mRNA levels were significantly decreased in the new cases of untreated MS patients in comparison to healthy controls.

9. Increased serum levels of S100B (show S100B Antibodies) protein (and NSE (show ENO2 Antibodies)) were observed postoperatively in patients with postoperative cognitive dysfunction.

10. high S100B (show S100B Antibodies) expression in Multiple Sclerosis (MS) patient samples suggests its usefulness as a diagnostic biomarker for MS.